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Monomeric and Polymeric Gram-Negative
Peptidoglycan but Not Purified LPS
Stimulate the Drosophila IMD Pathway
infections activate protease and phenoloxidase cas-
cades that lead to localized coagulation and melan-
ization (Hoffmann, 1995). Pathogens that enter into cir-
culation induce cellular and humoral antimicrobial
responses (Hoffmann, 2003). These responses include
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Summary ever, the detailed mechanisms of immune recognition
and signaling differ significantly between flies and hu-
Insects depend solely upon innate immune responses mans. In mammals, the Toll-like receptors (TLRs) appear
to survive infection. These responses include the acti- to directly recognize different microbial-derived, immu-
vation of extracellular protease cascades, leading to nostimulatory compounds. For example, TLR4 and its
melanization and clotting, and intracellular signal coreceptor MD-2 are thought to bind LPS (Visintin et
transduction pathways inducing antimicrobial peptide al., 2003), while TLR2 is required for recognition of lipo-
gene expression. In Drosophila, the IMD pathway is peptides and peptidoglycan. In mammals, peptidogly-
required for antimicrobial gene expression in response can also activates immunity through Nod2, an intracellu-
to gram-negative bacteria. The exact molecular com- lar receptor genetically linked to Crohn’s disease that
ponent(s) from these bacteria that activate the IMD recognizes the muramyl-dipeptide (MDP) fragment of
pathway remain controversial. We found that highly peptidoglycan (Girardin et al., 2003a; Inohara et al.,
purified LPS did not stimulate the IMD pathway. How- 2003). Similarly, a related intracellular protein, Nod1, is
ever, lipid A, the active portion of LPS in mammals, thought to specifically recognize gram-negative pepti-
activated melanization in the silkworm Bombyx morii. doglycan fragments (Chamaillard et al., 2003; Girardin
On the other hand, the IMD pathway was remarkably et al., 2003b).
sensitive to polymeric and monomeric gram-negative In Drosophila, activation of the IMD pathway by gram-
peptidoglycan. Recognition of peptidoglycan required negative bacteria requires the receptor PGRP-LC (Hoff-
the stem-peptide sequence specific to gram-negative mann, 2003). Drosophila encodes 13 PGRP family mem-
peptidoglycan and the receptor PGRP-LC. Recogni- bers, including PGRP-LC, a predicted transmembrane
tion of monomeric and polymeric peptidoglycan re- receptor (Werner et al., 2000), while humans have four
quired different PGRP-LC splice isoforms, while lipid PGRPs (Liu et al., 2001). PGRP-LC encodes three alter-
A recognition required an unidentified soluble factor natively spliced transcripts, PGRP-LCa, LCx, and
in the hemolymph of Bombyx morii. LCy, which each encode a protein with a unique
PGRP-motif containing extracellular domain linked to
Introduction the identical transmembrane and cytoplasmic domains
(Werner et al., 2003).
Insects rely on several innate effector mechanisms to The PGRP motif is structurally related to N-acetylmur-
effectively combat microbial pathogens. Wounding and amyl-L-alanine amidases, enzymes that hydrolyze the
bond between the lactyl group in N-acetylmuramic acid
and the L-alanine in the stem-peptide of peptidoglycan*Correspondence: neal.silverman@umassmed.edu
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(Kang et al., 1998). Several PGRPs have been shown fly cells. Recent experiments in mammals have demon-
to bind to insoluble peptidoglycan (Kang et al., 1998; strated that these preparations of LPS are often contam-
Takehana et al., 2002; Werner et al., 2000), and at least inated with other immunostimulatory bacterial cell wall
three PGRPs, PGRP-SC1B, PGRP-LB, and mouse components that, unlike LPS, stimulate TLR2. Once re-
PGRP-L, are able to enzymatically cleave peptidogly- extracted, E. coli LPS retains its specific TLR4 agonist
can, similar to other N-acetylmuramyl-L-alanine ami- properties but loses the ability to activate TLR2 (Hirsch-
dases (Gelius et al., 2003; Mellroth et al., 2003; Wang feld et al., 2000). We have used a bioassay to extensively
et al., 2003). Other PGRPs, like PGRP-LC, are not likely analyze our reextracted LPS and other microbial prod-
to have enzymatic activity because they are missing a ucts. This bioassay utilizes HEK293 cells that are stably
critical cysteine residue in the active site (Mellroth et expressing various human TLRs (Latz et al., 2002). The
al., 2003). parental HEK293 cells do not express TLR4 or TLR2 and
The compound(s) derived from gram-negative bacte- therefore do not respond to LPS or to various TLR2
ria that are recognized by PGRP-LC and activate the ligands, including lipopeptides and peptidoglycan (data
IMD pathway remain controversial. Many publications not shown). Stable expression of TLR4 and MD-2 cre-
have used relatively crude preparations of LPS to acti- ates a cell line that responds to LPS, as assayed by
vate the Drosophila immune response. However, Leulier ELISA for IL-8 production (Figure 1A). Similarly, expres-
et al. (2003) recently reported that adult flies respond, sion of TLR2 creates a cell line that responds to various
through PGPR-LC, to gram-negative peptidoglycan, TLR2 ligands, including peptidoglycan (Figure 1B). As
while highly purified LPS has little or no activity. They opposed to the commercial LPS, the reextracted LPS
further argue that monomeric peptidoglycan fragments is a potent and specific TLR4-dependent agonist, unable
are inactive and that recognition by PGRP-LC requires to activate TLR2-expressing cells even at doses as high
large macromolecular peptidoglycan polymers. How- as 100 g/ml (Figures 1A and 1B).
ever, these conclusions are compromised by the large Using the HEK293/TLR2 bioassay, as little as 100
immune induction caused by the negative control, the ng/ml of gram-negative peptidoglycan can be detected.
injection of water into adult flies, observed in these stud- Conversely, using the HEK293/TLR4/MD-2 bioassay, we
ies, which may mask the immunostimulatory activity of observed negligible activity with very high concentra-
the injected compounds. tions of gram-negative peptidoglycan. Also, using the
On the other hand, Werner et al. (2003) used enzymatic limulus amebocyte lysate assay, gram-negative pepti-
treatment to rid crude preparations of LPS of potential doglycan displayed only 1.2  102 EU/g, while reex-
peptidoglycan contaminants. Enzymatically “cleaned” tracted LPS has 1.17  103 EU/g, demonstrating that
LPS maintained a significant amount of immunostimula- the gram-negative peptidoglycan contains, at the most,
tory activity in Drosophila cells in culture (Werner et al., 0.001% LPS.
2003). Thus, these authors conclude that LPS is a potent In order to determine which of these compounds acti-
activator of the Drosophila immune response. Using vates the Drosophila immune response, the activities
these same reagents, these authors also argue that LPS of commercial and reextracted LPS preparations and
and peptidoglycan require different splice isoforms of various peptidoglycans were compared in S2* cells.
PGRP-LC for their recognition. However, these experi- These cells are an embryonic macrophage-like cell line
ments are also compromised because they did not that is particularly sensitive to immune stimulation fol-
demonstrate that enzymatic digestion of peptidoglycan, lowing a 24 hr period of differentiation with the insect
which contaminates crude LPS preparations, removes hormone 20-hydroxyecdysone (Dimarcq et al., 1997; Sil-
all peptidoglycan-induced immunostimulatory activity. verman et al., 2000). Activation of the IMD pathway was
Thus, no clear consensus has emerged as to the molecu- monitored by Northern blotting for the inducible expres-
lar mechanism(s) used by Drosophila to recognize gram-
sion of antimicrobial peptide genes such as diptericin,
negative bacteria.
attacin, and cecropin. Like commercial LPS, the reex-
In this study, the immunostimulatory activity of highly
tracted LPS is a potent activator of the insect immunepurified microbial products was analyzed in Drosophila
response, producing a robust response at concentra-cells and adults. Although highly purified LPS and syn-
tions as low as 100 ng/ml (Figure 1C). Polymeric gram-thetic lipid A did not stimulate the IMD pathway, lipid A
negative peptidoglycan (isolated from E. coli) is an evenactivated the insect phenoloxidase-melanization cas-
more potent activator of the insect immune response,cade. On the other hand, we found that gram-negative
inducing significant antimicrobial peptide gene expres-peptidoglycan, in its polymeric or monomeric forms, is
sion at concentrations 100-fold lower (1.0 ng/ml). Ona potent inducer of the IMD pathway. Using synthetic
the other hand, gram-positive peptidoglycan (isolatedpeptides similar to the stem-peptide of peptidoglycan,
from S. aureus) is a much weaker activator of the IMDwe observed that activation of the IMD pathway requires
pathway. This is consistent with experiments in adultthe gram-negative, stem-peptide-specific residue dia-
flies showing that gram-positive bacteria and gram-pos-minopimelic acid. Furthermore, we found that recogni-
itive peptidoglycan do not effectively activate the IMDtion of monomeric and polymeric peptidoglycan re-
pathway (Lemaitre et al., 1997; Leulier et al., 2003). Al-quired different splice isoforms of PGRP-LC.
though gram-positive, Bacillus subtilis produce pepti-
doglycan that is similar to gram-negative bacteria andResults
includes a diaminopimelic acid residue at the third posi-
tion of the stem-peptide. This type of peptidoglycan wasGram-Negative Peptidoglycan but Not Lipid A
also a potent stimulus of the IMD signaling pathway,Potently Activates the IMD Pathway
although not as potent as E. coli peptidoglycan. ThePrevious studies have used commercial LPS prepara-
tions to activate the insect immune response in flies and reduced potency of B. subtilis peptidoglycan may be
Peptidoglycan Not LPS Activates the IMD Pathway
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Figure 1. Gram-Negative Peptidoglcyan and
Reextracted LPS but Not Gram-Positive Pep-
tidoglycan Induce Antimicrobial Peptide
Gene Expression in Drosophila Cells
(A and B) IL-8 induction by human HEK293/
TLR4/MD2 cells (A) or HEK293/TLR2 cells (B)
stimulated with LPS or peptidoglycan as
marked. Reextracted LPS stimulates TLR4-
but not TLR2-expressing cells. On the other
hand, E. coli PGN stimulates TLR2- but not
TLR4-expressing cells. The error bars repre-
sent the standard deviation of three experi-
ments.
(C) Antibacterial peptide gene expression in
S2* cells stimulated with crude or reextracted
LPS or peptidoglycan from gram-negative or
gram-positive bacteria. Note, B. subtilis pep-
tidoglycan contains the amino acid DAP, sim-
ilar to gram-negative peptidoglcyan. Antibac-
terial peptide gene induction was analyzed
by Northern blotting with probes for diptericin
(dpt), attacin (att), cecropin (cec), and normal-
ized with a probe to Ribosomal protein 49
(rp49). The results exhibited are typical of at
least three experiments.
due to amidation of the DAP residues that are prevalent from that used by mammals and does not require lipid
A, or the reextracted LPS still contains a contaminantin the peptidoglycan from this microbe (Atrih et al., 1999).
Given the potency of polymeric peptidoglycan in Dro- that is a potent activator of the IMD pathway. Each of
these hypotheses is consistent with recent publicationssophila cells, it remains possible that activity observed
with the reextracted LPS is due to contaminating pepti- (Leulier et al., 2003; Werner et al., 2003).
doglycan. Therefore, we sought to identify chemically
synthesized LPS substructures that could activate the Lipid A Activates Melanization
In addition to antimicrobial peptide production, insectsDrosophila immune response. In mammals, the lipid A
head group, which can be chemically synthesized, is a respond to infectious microbes (and wounding) with lo-
calized melanin deposition. Melanization functions topotent stimulus of the innate immune response, through
TLR4 and MD-2 (Figure 2A). On the other hand, lipid A seal the wound, as well as to encapsulate and kill micro-
organisms. Melanization is tightly controlled by a num-is completely inactive in Drosophila cells (Figure 2B).
However, deacylated LPS, which has had the fatty acids ber of serine proteases, which activate prophenoloxi-
dases (which catalyze melanin synthesis), and serinechemically removed from the lipid A head group and is
inactive in mammals (Figure 2A), is a potent activator protease inhibitors (serpins), which inhibit the proteases
and limit melanization to the site of wounding and infec-of the Drosophila cells (Figure 2B). These data raise two
alternative possibilities: although LPS may stimulate the tions (De Gregorio et al., 2002). Microbial products acti-
vate the phenoloxidase-melanization cascade, a pro-IMD pathway, the mechanism of recognition is different
Immunity
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tracted LPS preparation. If LPS is the active component
in this preparation it should be insensitive to digestion
with enzymes that cleave peptidoglycan. Thus, we treated
the reextracted LPS with two peptidoglycan-digesting
enzymes: mutanolysin, which cleaves the glycan back-
bone, or PGPR-SC1B, which separates the glycan back-
bone from the stem-peptide. Using these treatments,
Werner et al. (2003) claimed to have removed the pepti-
doglycan from their commercial LPS preparations. We
find that while digestion of gram-negative peptidoglycan
with mutanolysin or SC1B reduces its stimulatory activ-
ity in S2* cells by 10- or 100-fold it does not eliminate
activity (Figure 4A). Moreover, although reextracted LPS
is still active after digestion with mutanolysin or PGRP-
SC1B when assayed at a high dose (1.0 or 10 g/ml,
respectively), a careful dose titration demonstrates that
activity drops 10- or 100-fold after digestion with muta-
nolysin or PGRP-SC1B, respectively (Figure 4B). These
results argue that the activity in Drosophila cells of the
reextracted LPS is, at least in part, due to peptidogly-
can contamination.
Therefore, the reextracted LPS was analyzed by acid
hydrolysis to release muramic acid (derived from the
peptidoglycan backbone), which is converted to alditol
acetate, followed by gas chromatography-tandem mass
spectrometry (Kozar et al., 2002). This highly sensitive
technique detected 627 ng of muramic acid per 1 mg
of reextracted LPS. Because muramic acid accounts for
Figure 2. Lipid A Does Not Activate Drosophila Cells approximately one-third of the molecular weight of E.
(A) IL-8 production by HEK293/TLR2 or HEK293/TLR4/MD2 cells coli peptidoglycan, this corresponds to a contamination
stimulated with synthetic lipid A or deacylated LPS. Lipid A but
level of0.2% (1.9 g/mg) of peptidoglycan in the reex-not deacylated LPS activates TLR4/MD2-expressing cells. TLR2-
tracted LPS. Thus, cells treated with 100 ng/ml reex-expressing cells do not respond to either compound.
tracted LPS will also be exposed to 0.2 ng/ml peptido-(B) Antimicrobial peptide gene expression in S2* cells treated with
synthetic lipid A or deacylated LPS, analyzed by Northern blotting. glycan, which may be sufficient to elicit a similar
Deacylated LPS but not lipid A stimulates the Drosophila immune re- response.
sponse. Thus, it is not clear if the activity of the reextracted
LPS is due solely to the peptidoglycan contaminants or
cess which has been best studied in the silkworm if LPS also has some activity. Therefore, to separate the
Bombyx morii. Ashida and colleagues have developed LPS from the contaminating peptidoglycan, the reex-
an in vitro assay, the silkworm larval plasma assay (SLP tracted LPS preparation was fractionated by gel filtration
assay), based on the in vitro melanization of silkworm and individual fractions were analyzed for LPS (by silver
hemolymph (Tsuchiya et al., 1996). Peptidoglycans and stain and HEK/TLR4/MD2 bioassays) and for induction
1-3  glucans are well-characterized activators of this of antimicrobial peptide genes in Drosophila cells (Fig-
reaction. In fact, this system was used to identify the ure 4C and Supplemental Figure S1 at http://www.
first peptidoglycan recognition protein (PGRP) (Yoshida immunity.com/cgi/content/full/20/5/637/DC1). As ex-
et al., 1996). Using this assay, 500 ng/ml of gram-nega- pected, LPS formed a single, high-molecular weight
tive peptidoglycan can be detected (Figure 3B), while peak centered near fractions 15 and 16 (MW, 1000 kDa).
as little as 10 ng/ml of insoluble gram-positive peptido- On the other hand, the Drosophila immunostimulatory
glycan can be detected (Figure 3A). Moreover, melaniza- activity formed a broad peak(s) between fractions 15 to
tion was activated by synthetic lipid A (which has no 25, with maximal activity at fraction 22 (MW, 100 kDa).
contaminating peptidoglycan due to the synthetic na- These results indicate that the vast majority of the activ-
ture of its preparation), although with less sensitivity (50 ity in the reextracted LPS is not due to the LPS. However,
g/ml) (Figure 3C). Thus, insects, at least Lepidoptera, because the Drosophila immunostimulatory activity par-
appear to use lipid A recognition to activate the extracel- tially overlapped with the LPS peak, these results do
lular protease cascades involved in melanization, similar not exclude the possibility that LPS has weak activity
to another arthropod, the horseshoe crab, that activates in Drosophila. Therefore, the reextracted, mutanolysin-
clotting cascades in response to lipid A. On the other digested LPS was similarly fractionated by gel filtration.
hand, lipid A-mediated activation of intracellular signal- In this case, a clear separation is apparent between LPS
ing pathways, which culminate in NF-B activation, ap- (whose chromatographic properties did not change) and
pears to be unique to mammals. the Drosophila immunostimulatory activity (Figure 4D
and Supplemental Figure S1 on Immunity’s website). In
this case, the peak activity was found in fractions 29–32,LPS Does Not Activate the IMD Pathway
In order to definitively determine if LPS activates the a molecular weight range of between 5 and 14 kDa.
These results demonstrate two important points: LPSDrosophila IMD pathway, we further analyzed the reex-
Peptidoglycan Not LPS Activates the IMD Pathway
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Figure 3. Lipid A Stimulates the Phenoloxidase-Melanization Cascade in Silkworm Larval Plasma
Activation of the insect melanization cascade was monitored with the silkworm larvae plasma (SLP) assay. Melanin formation is clearly
observed in the plasma treated with S. aureus peptidoglycan (A), E. coli peptidoglycan (B), and synthetic lipid A (C). (D) TCT, a monomeric
gram-negative peptidoglycan, does not stimulate the phenoloxidase-melanization cascade at concentration as high as 100 M (92 g/ml).
does not stimulate the IMD pathway, and the Drosophila is strongly activated by monomeric peptidoglycan. On
immunostimulatory activity present in the reextracted the other hand, a monomeric disaccharide-dipeptide
LPS is due to peptidoglycan, which is present at 0.2%. (GlcNAc-MDP) is almost completely inactive, displaying
Furthermore, based on the size of the active, muta- minimal immunostimulatory activity at very high doses
nolysin-treated sample, these results suggests that (100 g/ml) (Supplemental Figure S2 on Immunity’s
small fragments of peptidoglycan can activate the website).
IMD pathway. In the hamster tracheal system, synthetic lactyl-tetra-
peptides, which are identical to the noncarbohydrate
portion of TCT, are also capable of inducing cytotoxicityMonomeric Peptidoglycan Stimulates
(Luker et al., 1995). Lactyl-tetrapeptides similar to gram-the Drosophila IMD Pathway
positive bacterial peptidoglycan, with a lysine residueIn order to examine in more detail which substructures
instead of a diaminopimelic acid (DAP) residue at theof gram-negative peptidoglycan are specifically recog-
third position, are inactive in the tracheal assay. Similarly,nized by the Drosophila immune system, we tested the
in Drosophila cells, the gram-negative-like DAP-containingactivity of tracheal cytotoxin (TCT), a monomeric disac-
lactyl-tetrapeptide stimulates immune activation as as-charide-tetrapeptide fragment of peptidoglycan (Figure
sayed by antimicrobial peptide gene induction, while5A). TCT was originally isolated, from culture superna-
gram-positive-like lysine-containing lactyl-tetrapeptidestants of Bordetella pertussis, as an activity that damages
are inactive (Figure 5D). The lactyl-tetrapeptides are 102-hamster trachea epithelial cells (Cookson et al., 1989b).
to 106-fold less potent than intact TCT (when comparingIt has been proposed that TCT causes the severe respi-
attacin or diptericin expression, respectively), sug-ratory symptoms associated with B. pertusssis infection
gesting that the glycan portion of the molecule is re-(i.e., whooping cough). The receptor for TCT in the tra-
quired for optimal recognition. Most importantly, thecheal epithelium is not known, and, unlike larger frag-
specific response to gram-negative lactyl-tetrapeptidesments of gram-negative peptidoglycan, TCT does not
directly demonstrates that Drosophila discriminate be-stimulate TLR2-expressing cells (Figure 5B). Likewise,
tween gram-positive and gram-negative peptidoglycanthe SLP assay is insensitive to TCT at concentrations
by virtue of their different stem-peptide sequences.as high as 100 M (Figure 3D), suggesting that peptido-
Also, a synthetic DAP-containing tetrapeptide (with-glycan recognition by TLR2 and the SLP assay requires
out the lactyl group) was tested in a diptericin-luciferasepolymeric chains. However, Drosophila cells responded
reporter assay (Supplemental Figure S3 on Immunity’savidly to TCT, displaying significant induction of dipteri-
website). Similar to the activity observed in the hamstercin expression at concentrations as low as 10 pM (9
tracheal system, this tetrapeptide stimulated the IMDpg/ml) (Figure 5C). This demonstrates, contrary to the
conclusions of Leulier et al. (2003), that the IMD pathway pathway but with reduced efficiency. The DAP-con-
Immunity
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Figure 4. Peptidoglycan Not LPS Activates
the Drosophila Immune Response
(A) Treatment of gram-negative peptidogly-
can with PGRP-SC1B, which cleaves the
bond connecting the stem-peptide to the gly-
can backbone, reduces immunostimulatory
activity 10- to 100-fold. Similarly, digesting
with mutanolysin, which cleaves the glycan
backbone, reduces activity of gram-nega-
tive peptidoglycan.
(B) Likewise, digestion of reextracted LPS
with these same enzymes reduces activity
10- to 100-fold, suggesting that at least some
of the immunostimulatory activity of reex-
tracted LPS is due to contaminating pepti-
doglcyan. M, mock (enzyme  buffer)-treated
cells.
(C) Reextracted LPS was fractionated by size
exclusion chromatography (Superose 12).
Fractions were used to stimulate HEK293/
TLR4/MD2 cells or to stimulate Drosophila
S2* cells. As expected, LPS, as measured by
HEK293/TLKR4/MD2-stimulating activity or
by silver stain gel (see Supplemental Figure
S1 on Immunity’s website), elutes early, as
a sharp high-molecular weight peak. On the
other hand, the Drosophila immunostimula-
tory activity fractionates broadly, with peak
activity eluting significantly later than LPS.
(D) Reextracted LPS was digested with muta-
nolysin prior to chromatography. In this case,
the Drosophila immunostimulatory activity
elutes as a sharp low-molecular weight peak
that does not overlap with LPS. After mutano-
lysin digestion, the active fragments of pepti-
doglycan are all less than 14 kDa.
taining tetrapeptide displays30% of the potency com- adult flies were injected with increasing amounts of TCT
and expression of antimicrobial peptide genes was as-pared to DAP-containing lactyl-tetrapeptide, while the
lysine-containing lactyl-tetrapeptide has no activity. The sayed (Figure 5E). Injection of TCT was compared to
the injection of live E. coli or PBS. As seen previously,DAP-containing tetrapeptide corresponds to the prod-
uct produced by PGRP-SC1B digestion of gram-nega- injection of buffer alone causes weak and short-lived
antimicrobial peptide gene induction (Figure 5E andtive peptidoglycan.
Previously, Lemaitre and colleagues have suggested Supplemental Figure S4 on Immunity’s website). How-
ever, injection of either live bacteria or TCT, at concen-that small peptidoglycan fragments, such as TCT, do
not activate the IMD pathway in intact flies (Leulier et trations over 50 M, caused robust and long-lived anti-
microbial gene expression (Figure 5E and Supplementalal., 2003). On the other hand, the data presented above
demonstrate that TCT is a highly potent activator of the Figure S4 on Immunity’s website). In these experiments,
approximately 30 nl solution was microinjected intoDrosophila immune response in cell culture. In order to
determine if TCT also stimulates the IMD in intact animal, each fly; at 50 M, this corresponds to 1.5 ng of TCT
Peptidoglycan Not LPS Activates the IMD Pathway
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Figure 5. TCT Is a Potent Activator of the Drosophila Immune Response but Is Not an hTLR Agonist
(A) The structure of TCT, a monomeric fragment of gram-negative peptidoglycan.
(B) TCT fails to induce IL-8 in both TLR2- and TLR4/MD2-expressing cells. E. coli peptidoglycan (10 g/ml) and repurified LPS (100 ng/ml)
were used as a positive control for TLR2- and TLR4/MD2-expressing cells, respectively.
(C) TCT potently activates antimicrobial peptide gene expression in Drosophila cells, as monitored by Northern blotting.
(D) The stem-peptide sequence of gram-negative peptidoglycan is sufficient for specifically activating the IMD pathway. S2* cells were
stimulated with two synthetic stem-peptides, lactyl-L-Ala--D-Glu-L-Lys-D-Ala (gram-positive type) or lactyl-L-Ala--D-Glu-meso-DAP-D-Ala
(gram-negative type). Antibacterial peptide gene expression is observed in the cells stimulated with DAP-containing gram-negative type stem-
peptide but not with the lysine-containing gram-positive peptide.
(E) TCT activates the immune response in flies. Approximately 30 nl of TCT, at the indicated concentrations, was microinjected in adult flies.
The activity of TCT was compared to microinjection of sterile PBS or live E. coli cultures, at various OD600 values. Microinjection of 1.5 ng
(30 nl at 50 M) TCT clearly activated antimicrobial peptide gene expression, as measured by Northern blotting of total RNA from whole flies
24 hr after microinjection.
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per animal. Also, injection of TCT activated a dipt-LacZ Discussion
reporter, as assayed by X-gal staining, while injection
of PBS did not (data not shown) (Wu et al., 2001). The data presented here clearly demonstrate that LPS,
when separated from other microbial compounds (e.g.,
peptidoglycan), does not stimulate the Drosophila IMDMonomeric and Polymeric Peptidoglycan Are
Recognized by Different PGRP-LC Splice Isoforms pathway. A recent publication reaches the opposite con-
clusion (Werner et al., 2003), but in this case, the puritySeveral studies have demonstrated that the receptor
PGRP-LC is required for the response to gram-negative of the reagents was not adequately characterized. In
particular, it was assumed that PGRP-SC1B digestioninfection in vivo and the response to crude LPS prepara-
tions in tissue culture cells (Hoffmann, 2003). PGRP-LC of crude LPS would create peptidoglycan fragments
that are not able to stimulate the IMD pathway. On theencodes three alternatively spliced transcripts, LCa,
LCx, andLCy, with unique extracellular domains that contrary, the data presented here show that digestion of
gram-negative peptidoglycan with PGRP-SC1B reducesare attached to the same transmembrane and cyto-
plasmic domains (see Figures 6A and 6B) (Werner et al., but does not eliminate immunostimulatory activity and
that synthetic stem-peptides are also able to activate2000, 2003).
To test the role of specific PGRP-LC isoforms in the the IMD pathway. Moreover, although LPS is still active
following digestion with peptidoglycan-digesting en-response to the different immunostimulatory com-
pounds, RNAi was designed to target either the common zymes, careful dose response experiments show that
this activity is substantially reduced. Finally, fraction-region of PGRP-LC, thus reducing expression of all
PGRP-LC isoforms, or to target isoform-specific exons, ation of reextracted LPS by gel filtration chromatogra-
phy definitively demonstrates that LPS has no activitythus reducing expression of individual PGRP-LC iso-
forms (Figure 6A). RNAi-targeting of all PGRP-LC iso- in stimulating the IMD pathway; thus, the immunostimu-
latory activity found in various LPS preparations is dueforms prevented activation by either TCT or gram-nega-
tive peptidoglycan (Figures 6C and 6D). On the other to contaminating peptidoglycan.
The data presented here validate one conclusion ofhand, isoform-specific RNAi demonstrated discrete re-
ceptors for polymeric and monomeric peptidoglycan. Leulier et al. (2003), who injected adult flies with highly
purified LPS or gram-negative peptidoglycan. However,LCx RNAi potently inhibited immune induction by poly-
meric peptidoglycan treatment, while LCa RNAi had no these experiments were not conclusive because the
control, the injection of water alone, caused 100-foldeffect (Figure 6C). On the other hand, TCT recognition
required both the LCx and LCa isoforms, suggesting immune stimulation. Injection of gram-negative pepti-
doglycan caused a further 4-fold stimulation, while LPSPGRP-LCa and LCx isoforms are each contributing to
the TCT receptor (Figure 6D), perhaps as heterodimeric had no effect. This high background/low induction may
have masked the stimulatory effect of some injectedreceptor. The unique role of PGRP-LCa in recognition
of TCT, a monomeric peptidoglycan, suggests that the compounds. The results presented here, using a system
with a very high signal-to-noise ratio, definitively demon-LCa-specific extracellular domain is involved in mono-
mer specific interactions and/or the recognition of the strate that LPS does not to stimulate the IMD pathway.
These authors also claimed that monomeric peptidogly-1,6-anhydro arranged bond in the muramic acid compo-
nent of TCT. In polymeric peptidoglycan, this anhydro can does not activate the IMD pathway. (In this case,
monomers [or dimers] of disaccharide tetra- or tri-pep-arrangement occurs only at the termini of the sugar
backbone. Not surprisingly, given our conclusion that tides, with or without 1,6-anhydro-MurNAc, which were
produced by mutanolysin-digestion of peptidoglycan,activity of reextracted LPS is due to contaminating pep-
tidoglycan, the reextracted LPS requires only PGRP- were injected into flies.) Like the LPS injections, these
experiments were compromised by the high back-LCx, similar to polymeric gram-negative peptidoglycan
(Figure 6E). ground and the limited induction observed with poly-
meric peptidoglycan. On the other hand, the data pre-These findings suggest that PGRP-LC functions as a
dimeric receptor and that heteromeric combinations of sented here clearly demonstrate that TCT, a monomeric
disaccharide-tetrapeptide with a 1,6-anhydro-MurNAcvarious PGRP-LC isoforms allow for the recognition of
different microbial compounds. In order to examine this and a DAP-containing stem-peptide, is an incredibly
potent activator of the IMD pathway in cells and in flies.possibility, we established a stable cell line that ex-
presses differentially epitope-tagged versions of all Note that TCT is a single, HPLC-purified species that
has been validated by mass spectrometry. Therefore,three PGRP-LC isoforms. All the epitopes are encoded
as C-terminal fusions, and these proteins (PGRP-LCa- activation of PGRP-LC does not require larger poly-
meric peptidoglycan.FLAG,LCx-T7, andLCy-cMyc) were expressed from
the copper-inducible metallothionein promoter (Figure Both intact, polymeric gram-negative peptidoglycan
and monomeric peptidoglycan require the receptor7A). Using this cell line, we can detect each PGRP-LC
isoform on the cell surface by FACS analysis (Figure PGRP-LC to activate the IMD pathway. However, recog-
nition of monomeric peptidoglycan requires different7B), confirming the prediction that they are type II trans-
membrane proteins. Moreover, when PGRP-LCx is im- PGRP-LC splice isoforms than does polymeric pepti-
doglycan. Activation of the IMD pathway by monomericmunoprecipitated with anti-T7 antibody PGRP-LCa and
PGRP-LCy are coprecipitated. Likewise, PGRP-LCa TCT requires both the PGRP-LCa and LCx splice iso-
forms. This suggests that PGRP-LC functions as acoimmunoprecipitated PGRP-LCx or LCy (Figure 7C).
Thus, PGRP-LC isoforms can heterodimerize (or hetero- dimeric receptor, and that a LCa/LCx heterodimer
recognizes TCT. Consistent with this model, we demon-oligomerize) in various combinations to create different
recognition capabilities. strated that PGRP-LCx interacts with PGRP-LCa.
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Figure 6. Monomeric and Polymeric Peptidoglycan Require Distinct Alternatively Spliced Isoforms of PGRP-LC
(A) Diagram of the PGRP-LC locus with alternative transcripts LCa, LCx, and LCy indicated. Regions used for RNAi are indicated.
(B) PGRP-LC isoforms have a common intracellular domain with isoform-specific extracellular PGRP domains.
(C–E) The effect of RNAi on antimicrobial peptide gene expression induced by polymeric peptidoglycan (C), monomeric peptidoglycan (TCT)
(D), and reextracted LPS (E). S2* cells were transfected with dsRNA for LacZ, IKK, PGRP-LC (common), and its alternatively spliced
isoforms LCa, LCx, and LCy. Stimulation was performed with 100 nM of TCT, 100 ng/ml of E. coli peptidoglycan, or 1 g/ml of repurified
LPS for 5 hr and then RNA was isolated and examined by Northern blotting for antimicrobial peptide gene expression. “,” no stimulation;
“,” stimulation. Monomeric TCT requires PGRP-LCa in addition to –LCx, while polymeric peptidoglycan requires only –LCx.
While gram-negative peptidoglycan is a potent ago- DAP residue within peptidoglycan appears to be a major
mechanism by which gram-negative and gram-positivenist of PGRP-LC, gram-positive peptidoglycan has sig-
nificantly reduced ability to activate the IMD pathway. bacteria are discriminated. The reduced activity of the
lactyl-peptides, as compared to intact TCT, indicatesAlthough gram-negative and gram-positive peptidogly-
can have several differences, the stem-peptide sequence that the glycan portion of the molecule is required for
optimal recognition and signaling.found in gram-negative peptidoglycan is sufficient to
specifically activate the IMD pathway. Most gram-posi- While LPS and lipid A do not activate the IMD pathway,
recognition of lipid A is not completely absent in insectstives have a lysine residue in the third position of the
stem-peptide of peptidoglycan while gram-negative and other arthropods. Lipid A is well known to stimulate
the blood clotting cascade in the horseshoe crab. And,peptidoglycan contains a meso-DAP residue in the same
position. Chemically synthesized lactyl-tetrapeptides as shown here, lipid A also activates the melanization
cascade in the hemolymph of the silkworm Bombyxare capable of stimulating the IMD pathway only when
the peptide chain includes the DAP residue. Thus, the morii. Interestingly, both of these pathways require lipid
Immunity
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Figure 7. PGRP-LC Isoforms Form Heterodimeric Receptor Complexes
(A) A stable cell line expressing all three PGRP-LC isoforms with different C-terminal tags (LCa-FLAG, LCx-T7, and LCy-cMyc) under the
control of the copper-inducible metallothionein promoter was generated (PGRP-LCaxy cells). Expression of each PGRP-LC isoform was
detected, after 2 hr copper treatment, by immunoblotting whole-cell lysates with the appropriate antibody. The PGRP-LC proteins are not
detected in extract from a control cell line, which includes the empty vector (Vec).
(B) FACS analysis on live PGRP-LCaxy cells, after 2 hr copper treatment (black lines) or prior to copper treatment (gray lines), simultaneously
with three antibodies labeled with three different dyes shows that all three PGRP-LC isoforms are type II transmembrane proteins with
extracellular C-terminal epitope tags.
(C) PGRP-LC splice isoforms coimmunoprecipitate. PGRP-LCx or PGRP-LCa complexes were immunoprecipitated from whole-cell lysates,
from cells treated with copper for 2 hr, or untreated, with appropriate antibodies and analyzed by immunoblotting for all three PGRP-LC
isoforms. Each PGRP-LC isoform interacts with the other two isoforms. Extract from a cell line that includes only the empty vector does not
exhibit any of the PGRP-LC-specific bands.
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PGRP-SC1B and mutanolysin (Sigma) digestion of reextractedA to activate a serine protease cascade. The silkworm
LPS and peptidoglycan samples were performed according to themelanization cascade is not particularly sensitive to lipid
published methods (Mellroth et al., 2003; Popham et al., 1996).A; 50 g/ml is required to drive melanization. Thus, a
Fractionation of reextracted LPS was performed with an FPLC
high local concentration of LPS, as found on the surface system (Pharmacia) according to the method by Chamaillard et al.
of gram-negative bacteria, may be necessary drive the (2003). In brief, 600 g of reextracted LPS was fractionated on a
melanization reaction. Superose-12 column and 0.5 ml fractions were collected. Dextran
blue-2000, thyroglobulin (669 kDa), catalase (232 kDa), ovalbuminMore experiments are required to determine the
(43 kDa), and ribonuclease A (13.7 kDa) were used as molecularmechanism by which lipid A is recognized in the silk-
weight standards (Amersham Biosciences).worm and to determine if lipid A also stimulates melani-
zation in Drosophila. It will be interesting to learn if the
Drosophila Cells and Northern Blotting
proteins responsible for lipid A recognition in the insect S2* cells and RNA analysis techniques used in this study were
melanization cascade are similar to factor C, the lipid described previously (Silverman et al., 2000). Epitope-tagged PGRP-
A-sensing serine protease zymogen responsible for ini- LC isoforms were generated by PCR and cloned into the pRmHa3.
Stable cell lines were selected with G418 as described previouslytiating the clotting cascade in horseshoe crabs (Muta
(Silverman et al., 2000). PGRP-LCs were expressed from the metallo-et al., 1993). The factor C prodomain includes several
thionein promoter following the addition of 500 M copper sulfatesushi domains, which are critical for the detection of
for 2 hr. Immunoblotting was performed with rabbit anti-FLAG
lipid A (Muta et al., 1993; Tan et al., 2000). The Drosophila (Sigma), anti-T7 monoclonal (Novagen), or cMyc monoclonal anti-
genome encodes one serine protease that contains a bodies (Santa Cruz) and with appropriate anti-IgG-HRP and visual-
sushi motif within its prodomain and is thus a candidate ized with West Pico SuperSignal (Pierce). Flow cytometry was per-
formed with FITC-conjugated anti-FLAG-M2 antibodies (Sigma),lipid A sensor. It has been reported that lipid A also
biotin-conjugated anti-T7 antibodies (Novagen), streptavidin-alexaactivates the complement cascade, an immunoprotec-
Fluor 633 (Molecular Probes), and PE-conjugated anti-cMyc (Santative serine protease cascade found in humans (Vukajlo-
Cruz). Coimmunoprecipitations were performed as described pre-vich et al., 1987). Perhaps lipid A activates complement
viously (Silverman et al., 2000) with FLAG-M2-agarose (Sigma) or
by a similar mechanism; a number of complement zymo- anti-T7 monoclonal (Novagen) with protein G agarose (Sigma).
gens contain sushi domains within their prodomain.
It is interesting that, while mammals utilize at least ten Human Cell Lines and ELISA for IL-8
Toll receptors to recognize different microbial products, The stable cell lines of human embryo kidney (HEK) 293 cells ex-
pressing YFP-fused hTLR2 or CFP-fused hTLR4 and retroviral MD-2they also have four PGRP homologs. Our understanding
were described previously (Latz et al., 2002). We plated 40,000 cellsof the role of the mammalian PGRPs in immune recogni-
in 200 l of medium into a 96-flat-well culture plate. After 6 hr fortion is limited. Mouse PGRP-L was recently shown to
attachment, cells were stimulated with various compounds for 18
have N-acetylmuramyl-L-alanine amidase activity, simi- hr and then supernatants were analyzed for IL-8 by ELISA, according
lar to PGRP-SC1B, and thus is likely to function as a to the manufacture’s protocol (R & D, Minneapolis, MN).
scavenger, degrading bacterial debris. Mice with the
PGRP-S gene ablated are susceptible to infection with RNAi Experiments
dsRNA was synthesized from a PCR-amplified template, with T7nonpathogenic gram-positive bacteria, and their neutro-
promoter sequences flanking the gene interest, using the Ribomaxphils are defective in killing these bacteria (Dziarski et
kit from Promega (Madison, WI) or Megascript RNAi kit from Ambional., 2003). PGRP-S may function as a pattern recognition
(Austin, TX) as described before (Silverman et al., 2000). The actual
receptor that controls the oxidative burst in neutrophils. and predicted nucleotide sequence for PGRP-LC alternative splicing
PGRP-I or -I are not yet functionally characterized. isoforms a, x, and y and the common region were determined using
The mammalian receptor for TCT has not yet been identi- Genbank and the report of Werner et al. (2000), as shown in Figure
6A. The sequences of primers, used for amplification of templates forfied. The similar specificity of PGPR-LC mediated recog-
dsRNA production, are as listed in the Supplemental Experimentalnition and signaling in Drosophila and cytotoxicity of
Procedures (available on Immunity’s website). After in vitro tran-TCT in the hamster tracheal assay suggests that one of
scription, dsRNA were treated with DNase and purified by phenol/the mammalian PGRPs may be the TCT receptor.
chloroform extraction, gel filtration, and ethanol precipitation. Trans-




MicroinjectionsEscherichia coli O111:B4 LPS was purchased from Sigma-Aldrich
Microinjections into 2- to 5-day-old female y w DD1;cn bw adults(St. Louis, MO) and reextracted with acid phenol and detergent as
were performed as described previously (Wu et al., 2001). In brief,described previously (Hirschfeld et al., 2000). Deacylated E. coli LPS
30 nl of solution was injected with a microinjection needle andwas obtained from Sigma. E. coli-type lipid A, compound 506, was
holder attached to a 10 ml syringe. The pressure in the needle wassynthesized as described (Liu et al., 1999). S. aureus-insoluble pepti-
adjusted so that it would release solution when inserted into thedoglycan and B. subtilis peptidoglycan were obtained from Sigma.
body cavity. The site of injection was in the abdomen, just posteriorInsoluble E. coli peptidoglycan was purified essentially as described
to the thorax on the lateral side.for muropeptide purification except that trypsin was used instead of
pronase, and the final muramidase treatment was omitted (Glauner,
Acknowledgments1988). Tracheal cytotoxin (TCT) was isolated from the culture me-
dium of Bordetella pertussis (Cookson et al., 1989a). Lactyl-tetra-
We would like to thank Eicke Latz for assistance with the TLR-peptides were synthesized as reported (Luker et al., 1995). All com-
expressing HEK cell lines; Dan Kelliher and Reid Gilmore for assis-pounds used were tested for pyrogenic activity with the limulus
tance with fractionation of LPS; L. Wu for assistance with microinjec-amebocyte lysate chromogenic assay (BioWhittaker, Walkersville,
tion; J.-L. Imler for the reporter plasmid; and Peihong Guan forMD). Silkworm larvae plasma assay (Wako, Osaka, Japan) was per-
technical assistance. This work was supported by NIH grantsformed according to the manufacturer’s instruction with minor modi-
GM54060, DK50305, and AI52455 (to D.G.); AI060025 (to N.S.); andfications. SLP reagent was reacted with bacterial compounds in the
by the Commission of the European Communities grant QLK2-2000-96-well plate at 30	C for 60 min, followed immediately by determina-
tion of absorbance at 650 nm. 336, HOSPATH (to D.G. and H.S.).
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